Search

everythinglearnresearchcommunity

for

Search:↓

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Keratin 15 is not a reliable sole marker for identifying epidermal stem cells because it's found in various cell types.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Nonionic liposomes are the best for delivering genes to skin cells.

Human hair follicle cells can grow hair when put into mouse skin if they stay in contact with mouse cells.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The conclusion is that a new biopsy technique and humidity chamber help study skin mites better and suggest mite overpopulation may cause skin diseases.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Bimatoprost is safe and effective for improving eyebrow hair.